Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-10-20
1982-09-07
Siegel, Alan
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
4242485, 42424852, 42424859, 42424855, 424250, 424263, 424267, 424283, 426532, 2601125R, 560 9, 560 12, 560 13, 560 16, 560 22, 560 29, 546186, 546193, 546224, 546244, 546264, 546348, 544 78, 544111, 544124, 544130, 544163, 544164, 544359, 544360, 544382, 549424, A23L 334, C07C 7946, C07C14940, C07C14367, A01N 4710, A01N 4384, A01N 4348, A01N 4340
Patent
active
043484069
ABSTRACT:
Compounds of the formula: ##STR1## and their pharmaceutically acceptable acid addition salts, useful as anthelmintics are disclosed.
REFERENCES:
patent: 3941824 (1976-03-01), Fuchs
patent: 4097673 (1978-06-01), Fuchs
Eisen Bruce M.
Ginsburg Paul H.
Magnatti Anita W.
Schering Corporation
Siegel Alan
LandOfFree
Novel guanidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel guanidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel guanidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1342249